首页> 外文期刊>Circulation journal >Elevated Serum Heart-Type Fatty Acid-Binding Protein in the Convalescent Stage Predicts Long-Term Outcome in Patients Surviving Acute Myocardial Infarction
【24h】

Elevated Serum Heart-Type Fatty Acid-Binding Protein in the Convalescent Stage Predicts Long-Term Outcome in Patients Surviving Acute Myocardial Infarction

机译:恢复期血清心型脂肪酸结合蛋白升高可预测急性心肌梗死患者的长期结果

获取原文
           

摘要

Background: ?Little is known about the prognostic significance of elevated serum heart-type fatty acid-binding protein (H-FABP) in post-acute myocardial infarction (post-AMI) patients. Methods and Results: ?A total of 1,283 post-AMI patients with available serum samples collected in the convalescent stage were studied. During a median follow-up period of 1,785 days, 176 patients (14%) had adverse events (all-cause mortality, n=81; non-fatal MI, n=44; readmission for heart failure [HF], n=51). Patients were divided into 2 groups according to a serum H-FABP level of 6.08ng/ml, which was determined to be the optimal cut-off for discriminating all-cause mortality based on the maximum value of the area under the receiver operating characteristic curve. Patients with elevated H-FABP (>6.08ng/ml, n=224) had a significantly higher incidence of death (18.3% vs. 3.8%, P
机译:背景:对于急性心肌梗死(AMI后)患者血清心脏型脂肪酸结合蛋白(H-FABP)升高的预后意义知之甚少。方法和结果:共研究了1,283名AMI后患者在康复期收集的可用血清样本。在中位随访期1,785天中,有176例患者(占14%)发生不良事件(全因死亡率,n = 81;非致命性MI,n = 44;因心力衰竭再次入院[HF],n = 51) )。根据血清H-FABP水平6.08ng / ml将患者分为两组,根据受试者工作特征曲线下面积的最大值,将其确定为区分全因死亡率的最佳临界值。 H-FABP(> 6.08ng / ml,n = 224)升高的患者死亡发生率显着更高(18.3%vs. 3.8%,P

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号